# # 当代AI基础模型加剧生物武器风险

发布时间：2025年06月12日

`LLM应用` `生物安全` `人工智能`

> Contemporary AI foundation models increase biological weapons risk

# 摘要

> 人工智能的快速发展引发了对其可能促进生物武器开发的担忧。我们主张，现有对当代基础AI模型的安全性评估低估了这一风险，这主要归因于错误的假设和不充分的评估方法。首先，评估错误地认为生物武器的研发需要 Tacit knowledge（隐性知识），即通过实践获得的难以言传的技能。其次，它们依赖于不完美的基准，忽视了AI如何提升非专家和已有技能的人的能力。为了挑战 Tacit knowledge 的假设，我们研究了没有正式专业知识的人成功完成复杂技术任务的案例，包括2011年挪威的超民族主义者成功合成爆炸物。我们还审查了记录病原体构建过程的努力，突显了这些任务如何能够通过文本传达。我们确定了大型语言模型可以描述的“成功要素”，包括获取材料和执行技术程序等步骤。应用这一框架，我们发现，先进的AI模型（如Llama 3.1 405B、ChatGPT-4o和Claude 3.5 Sonnet）能够准确指导用户从商业获取的合成DNA中恢复活体脊髓灰质炎病毒，这挑战了近期声称当前模型对生物安全风险极小的说法。我们主张改进评估基准，同时承认实施这些改进的窗口可能已经关闭。

> The rapid advancement of artificial intelligence has raised concerns about its potential to facilitate biological weapons development. We argue existing safety assessments of contemporary foundation AI models underestimate this risk, largely due to flawed assumptions and inadequate evaluation methods. First, assessments mistakenly assume biological weapons development requires tacit knowledge, or skills gained through hands-on experience that cannot be easily verbalized. Second, they rely on imperfect benchmarks that overlook how AI can uplift both nonexperts and already-skilled individuals. To challenge the tacit knowledge assumption, we examine cases where individuals without formal expertise, including a 2011 Norwegian ultranationalist who synthesized explosives, successfully carried out complex technical tasks. We also review efforts to document pathogen construction processes, highlighting how such tasks can be conveyed in text. We identify "elements of success" for biological weapons development that large language models can describe in words, including steps such as acquiring materials and performing technical procedures. Applying this framework, we find that advanced AI models Llama 3.1 405B, ChatGPT-4o, and Claude 3.5 Sonnet can accurately guide users through the recovery of live poliovirus from commercially obtained synthetic DNA, challenging recent claims that current models pose minimal biosecurity risk. We advocate for improved benchmarks, while acknowledging the window for meaningful implementation may have already closed.

[Arxiv](https://arxiv.org/abs/2506.13798)